Pfizer and BioNTech are poised to begin their first clinical trial with a new vaccine candidate adapted to offer protection against the Omicron variant of the coronavirus...
Germany’s Evonik is investing a three-digit million-euro sum to build a new plant for producing bio-based and fully biodegradable rhamnolipids in Slovakia. The facility...
Unilever’s CEO Alan Jope has had to bury his hopes of buying GlaxoSmithKline’s consumer drugs portfolio. After shareholders questioned the move, and analysts said that...
Up to now, the name BioNTech has popped up mostly in one breath with Pfizer, the company’s US partner in developing the mRNA-based Covid-19 vaccine marketed as Comirnaty...
Pfizer and BioNTech expect to have a modified version of their mRNA-based Covid-19 vaccine ready to tackle the Omicron variant by March, Pfizer CEO Albert Bourla said on...
Innovation protection with the EU Unitary Patent will be more uniform and less costly, but it also carries risks.
The UK’s Hikma Pharmaceuticals has agreed to pay $45.75 million for the Canadian business of Teligent, a US generic drugmaker that filed for Chapter 11 bankruptcy...
Aceto, a US-based manufacturer of specialty materials for life sciences and advanced technology end markets, has consolidated and integrated six recent acquisitions with...
Storage conditions play a vital role in the entire supply chain of pharmaceutical products and must comply with strict regulations. From manufacturers to patients...
The positive impacts of Predictive Maintenance are broad and should be considered holistically. No one ever said that nurturing a perfect rose garden was simple, but the...
Interview with Steven De Laet, InOpSys
Interview with Oliver Reimann and Andreas Regnery, Belyntic
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | Twitter
We keep you posted - Subscribe to the CHEManager International newsletter here!
The ability to meet growing regulator and societal demands for high-quality, safe, sustainable, and compliant products is a strategic imperative.
The poor healing ability of tendons as well as the limitations of currently used therapies have motivated tissue engineering (TE) strategies to develop living tendon...
Cosmetic products often consist of a long list of ingredients, including potentially harmful substances. The identification and precise quantification of these substances...